ACADIA Pharmaceuticals Inc Free Cash Flow Generation Index
ACADIA Pharmaceuticals Inc free cash flow generation index. ACADIA Pharmaceuticals Inc (ACAD) has a Free Cash Flow Generation Index of 0.92x as of June 2026. Free cash flow of $124.46 Million represents 1% of operating cash flow ($134.76 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of ACADIA Pharmaceuticals Inc (2023–2025)
Free cash flow generation index of ACADIA Pharmaceuticals Inc from 2023 to 2025. Historical FCF Generation Index trend for ACADIA Pharmaceuticals Inc across 3 annual periods. See ACAD FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
ACADIA Pharmaceuticals Inc Free Cash Flow Generation Index by Year (2023–2025)
ACADIA Pharmaceuticals Inc free cash flow generation index by year from 2023 to 2025. Year-by-year Free Cash Flow Generation Index for ACADIA Pharmaceuticals Inc. For the full cash flow conversion analysis, see ACADIA Pharmaceuticals Inc (ACAD) cash flow conversion.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | $105.15 Million | $109.84 Million | $4.69 Million | ▼ -4.0% |
| 2024 | 1.00x | $157.20 Million | $157.72 Million | $523.00K | ▲ +171.3% |
| 2023 | -1.40x | $-23.35 Million | $16.70 Million | $40.05 Million | — |